JP Patent

JP7575217B2 — レベチラセタムを含む錠剤

Assigned to 日本ジェネリック株式会社 · Expires 2024-10-29 · 2y expired

What this patent protects

Patent listed against Keppra.

Drugs covered by this patent

Keppra (levetiracetam) · Generic (originally UCB Pharma)

Patent Metadata

Patent number: JP7575217B2
Jurisdiction: JP
Classification: —
Expires: 2024-10-29
Drug substance claim: No
Drug product claim: No
Assignee: 日本ジェネリック株式会社
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.